Tag: Cancer: Prostate
Certain Prostate Drugs Tied to Risk for Parkinson Disease
Use of glycolysis-enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin
Drop in PSA Screening Linked to Increase in Metastatic Prostate Cancer
Across states, reductions in PSA screening linked to increased incidence of metastatic prostate cancer at diagnosis
FUS Ablation Feasible for Intermediate-Risk Prostate Cancer
In small phase II study, 93 percent free of clinically significant prostate cancer at treatment site at five-month biopsy
Mediterranean Diet Tied to Lower Risk for Prostate Cancer Progression
Risk lower for men with newly diagnosed prostate cancer on active surveillance protocol
Higher Coffee Intake May Reduce Risk for Prostate Cancer
Pooled relative risk of 0.988 for each increment of one cup of coffee per day revealed in meta-analysis of cohort studies
FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer
Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone
Prostate Cancer Pathology Not Worse With Delayed Surgery
Delayed radical prostatectomy not linked to higher risk for adverse pathological outcomes in high-risk prostate cancer
Black Men Experience More Treatment Regret With Prostate Cancer
Higher medical mistrust and concerns about masculinity may contribute to regret
FDA Approves Drug for PET Imaging of Prostate Cancer
Approval of Gallium 68 PSMA-11 provides new imaging approach to detect prostate cancer metastasis or recurrence
Prognosis Good With Negative Biopsy in Active Surveillance
Negative biopsies during active surveillance for low-risk prostate cancer tied to more favorable outcomes
